Key result
Long-term methyldopa links to frequent drowsiness and dizziness, with impotence reported in ~16% of men.
Why the study?
This study presents tolerability data recorded during the long-term administration of methyldopa.
What are the clinical adverse effects associated with long-term administration of methyldopa?
Cohort
What are the clinical adverse effects associated with long-term administration of methyldopa?
Long-term antihypertensive regimens containing methyldopa are commonly associated with drowsiness, dizziness, and a 16% rate of reported impotence in men, though concomitant therapy limits causal attribution.
Answers are grounded in this paper and cite their sources.
Supports vigilance for drowsiness, dizziness, and impotence in men on long-term methyldopa; leaves open causality amid concomitant therapies in observational cohorts.
Tolerability data recorded during long-term administration of methyldopa are presented here. Since diuretics and other antihypertensive agents were frequently coadministered with methyldopa, no attempt was made to assign possible drug relationships for any particular adverse effect. The most common clinical adverse effects among the entire study population were drowsiness and dizziness. Impotence was reported by 16% of 258 men.
No takes yet. Share an insight, caveat, or question.
James C. Metts (1981) conducted a cohort in Hypertension. Methyldopa was evaluated on Clinical adverse effects (including drowsiness, dizziness, and impotence in men). Long-term methyldopa administration was most commonly associated with drowsiness and dizziness, with impotence reported by 16% of 258 men.
Synapse has enriched 10 related papers. Consider them for comparative context: